Arrow
Arrow
Liv Doctors
Arrow
Assoc. Prof. MD. Şefika Nur Aksoy
Assoc. Prof. MD. Şefika Nur Aksoy
Assoc. Prof. MD.

Şefika Nur Aksoy

Liv Hospital Gaziantep
Biochemistry Laboratory
Areas of Interests
    • Research award AACC annual Meeting July 25-29,2004, Los Angeles, California
    • Industry Award at the 2009 35th National Hematology Congress organized by the Turkish Hematology Association / ''Investigation of Myeloperoxidase G-463a Polymorphism and Enzyme Levels in Chronic Lymphocytic Leukemia and Multiple Myeloma''
    • V.National Emergency Medicine Congress 19-22 April 2009, first prize in Dr. John Fowler Honor award in oral presentation / The prognostic role of Ca-125 and NT pro-BNP in Acute Decompensated Heart Failure with pleural effusion
Resume
Publications
Memberships
Education
  • Istanbul Girls High School
  • Cerrahpasa Faculty of Medicine
Experience
  • Suluova SSK Hospital (Compulsory Service)
  • Cibali SSK Dispensary
  • Haseki Training and Research Hospital / Medical Biochemistry
  • 75.year Maternity Hospital - Gaziantep
  • Vocational School of Health Services / Gaziantep University
  • Faculty of Medicine, Department of Biochemistry and Clinical Biochemistry/ Gaziantep University Assistant Professor (2006 - 2011)
  • Faculty of Medicine, Department of Biochemistry and Clinical Biochemistry/ Gaziantep University Associate Professor (2011 - 2016)
  • GAUN Medical Faculty Hospital Laboratory responsible faculty member (2008 - 2016)
  • Diyarbakır Memorial Hospital (01-06-2016)
  • Kolan International Hospital - Istanbul (2019 - 2020)
  • Aksoy ŞN, Savaş E, Sucu M, Kisacik B, Kul S, Zengin O. Association between red blood cell distribution width and disease activity in patients with Behçet's disease. J Int Med Res. 2015 Dec;43(6):765-73
  • Akcali A, Zengin F, Aksoy SN, Zengin O. Fatigue in Multiple Sclerosis: Is it related to cytokines and hypothalamic-pituitary-adrenal axis? Mult Scler Relat Disord. 2017 Jul;15:37-41.  
  • Tabur S, Aksoy ŞN, Korkmaz H, Ozkaya M, Aksoy N, Akarsu E. Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma. Tumour Biol. 2015 Apr;36(4):2667-74. 
  • Dai AI, Aksoy SN, Demiryürek AT. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity. J Child Neurol. 2016 Feb;31(2):184-9
  • Tabur S, Korkmaz H, Ozkaya M, Aksoy SN, Akarsu E. Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy? Diabetol Metab Syndr. 2015 Apr 24;7:36
  • Dai AI, Demiryürek S, Aksoy SN, Perk P, Saygili O, Güngör K. Maternal Iron Deficiency Anemia as a Risk Factor for the Development of Retinopathy of Prematurity. Pediatr Neurol. 2015 Aug;53(2):146-50.
  • Korkmaz H, Tabur S, Savaş E, Özkaya M, Aksoy ŞN, Aksoy N, Akarsu E. Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases. Balkan Med J. 2016 Sep;33(5):547-551. 
  • Çetkin M , Demirel C, Kızılkan N, Aksoy N, Erbağcı H. Evaluation of the mobile phone electromagnetic radiation on serum iron parameters in rats. Afr Health Sci. 2017 Mar; 17(1): 186–190.
  • Evaluation of oxidant and antioxidant status and relation with prolidase in systemic sclerosis. Savas E, Aksoy N, Pehlivan Y,  Sayiner ZA, Oztürk ZA,  Tabur S, Orkmez M, Onat AM.    Wien Klin Wochenschr. 2014 Jun;126(11-12):341-6. 
  • Aksoy SN , Saygılı EI , Bulbul F , Bahar A , Savas H, Vırıt O , Altındag A , Bayram A and Tarakçıoğlu M. Myeloperoxidase enzyme levels and oxidative stress in bipolar disorders. Afr. J. Biotechnol 9 (22), 3318-3323, May 2010
  • Saygili E.I, Aksoy SN, Gurler B, A. Aksoy, O. Erel & M. Ozaslan Oxidant/Antioxidant Status of Patients with Diabetic and Senile Cataract. Biotechnol. & Biotechnol. Eq., 24(1), 1648-1652, 2010
  • Aksoy SN, Erbagci Z, Saygili EI, Sever T, Erbagci AB, Pehlivan S. Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo. Eur J Dermatol. Nov-Dec 2009;19(6):576-80
  • Aksoy N, Aksoy M, Cakmak M, Gergerlioglu HS, Davutoglu V, Soydinc S, Meram I “ Increased homocysteine in heart failure: a result of renal impairment? “,Clin chem Lab Med .44(11):1324-1329 (2006)
  • Aksoy N, Aksoy M, Bagci C, Gergerlioğlu HS, Çelik H, Herken E, Yaman A, Tarakçıoğlu M,Soydinç S, Sari I, Davutoğlu. ‘’Pistachio intake increases high density lipoprotein levels and inhibits low density lipoprotein oxidation in rats’’,Tohoku J Exp Med.212(1):43-8 (2007)
  • Aksoy N, Ozer O, Sari I, Sucu M, Aksoy M, Geyikli I. ‘’Contribution of Renal Function Impairment to Unexplained Troponin T Elevations in Congestive Heart Failure. Renal Failure, 31(4):272–277 (2009)
  • Saygili EI, Aksoy N, Pehlivan M, Sever T, Yilmaz M, Cimenci IG, Pehlivan S. Enzyme levels and G-463A polymorphism of myeloperoxidase in chronic lymphocytic leukemia and multiple myeloma. Leuk Lymphoma. 2009 Oct 9.
  • Dinçkal MH, Aksoy SN, Aksoy M,Davutoğlu,Dinçkal N, Akdemir I,”QT dispersion  in the risk stratification of patients with unstable angina : correlation with clinical course ,troponin T and scintigraphy.” Acta Cardiol.59(3):283-9 (2004)
  • Dinçkal MH, Aksoy N, Aksoy M, Davutoğlu V,Soydinç S,Kirilmaz A,Dinçkal N,Akdemir I “Effect of homocysteine-lowering therapy on vascular endothelial function and exercise  performance in coronary patients with hyperhomocysteinaemia.”Acta Cardiol.58(5):389-96(2003)
  • Akdemir I, Aksoy N, Aksoy M, Davutoğlu V, Dinçkal H,” Does exercise induced severe ischemia result in elevation of plasma troponin-T level in patients with chronic coronary disease,”Acta Cardiol.,57(1):13-8 (2002)
  • Dinçkal MH, Aksoy N, Aksoy M, Davutoğlu, Dinçkal N, Soydinç S, Akdemir I,”Acute rest perfusion imaging in high risk unstable angina :association with troponin T and clinical endpoints”,Int J Cardiovasc Imaging,19(6):511-7 (2003)
  • Sari I, Baltaci Y, Bagci C, Davutoglu V, Erel O, Celik H, Ozer O, Aksoy N, Aksoy M. Effect of pistachio diet on lipid parameters, endothelial function, inflammation, and oxidative status: A prospective study. Nutrition. 2009; 1–6
  • Ozer O, Davutoglu V, Ercan S, Akcay M, Sari I, Sucu M, Celik A, Aksoy N, Cicek H, Al B.Plasma urotensin II as a marker for severity of rheumatic valve disease.Tohoku J Exp Med. 2009 May;218(1):57-62 
  • Erbağcı AB, Deveci R, Akarsu E, Tiryaki Ö, Aksoy ŞN. Effect of intensive insulin therapy on systemic nitric oxide levels and adenosine deaminase activity in secondary sulfonylurea failure. Biochemia Medica 2009;19(2):166–76
  • Turkish Biochemistry Association
  • Turkish Society of Clinical Biochemistry
Ask our Experts!
You can contact with our experts for your questions!